Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Injectable Biodegradable Chitosan-Alginate 3D Porous Gel Scaffold for mRNA Vaccine Delivery.

Yan J, Chen R, Zhang H, Bryers JD.

Macromol Biosci. 2019 Feb;19(2):e1800242. doi: 10.1002/mabi.201800242. Epub 2018 Nov 16.

2.

Scaffold-mediated delivery for non-viral mRNA vaccines.

Chen R, Zhang H, Yan J, Bryers JD.

Gene Ther. 2018 Dec;25(8):556-567. doi: 10.1038/s41434-018-0040-9. Epub 2018 Sep 21.

3.

Protein Engineering Reveals Mechanisms of Functional Amyloid Formation in Pseudomonas aeruginosa Biofilms.

Bleem A, Christiansen G, Madsen DJ, Maric H, Strømgaard K, Bryers JD, Daggett V, Meyer RL, Otzen DE.

J Mol Biol. 2018 Oct 12;430(20):3751-3763. doi: 10.1016/j.jmb.2018.06.043. Epub 2018 Jun 30.

4.

Precision-porous templated scaffolds of varying pore size drive dendritic cell activation.

Chen R, Ma H, Zhang L, Bryers JD.

Biotechnol Bioeng. 2018 Apr;115(4):1086-1095. doi: 10.1002/bit.26532. Epub 2018 Jan 22.

5.

Chemical and Physical Variability in Structural Isomers of an l/d α-Sheet Peptide Designed To Inhibit Amyloidogenesis.

Maris NL, Shea D, Bleem A, Bryers JD, Daggett V.

Biochemistry. 2018 Feb 6;57(5):507-510. doi: 10.1021/acs.biochem.7b00345. Epub 2017 Dec 19.

6.

Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.

Katzenmeyer KN, Szott LM, Bryers JD.

Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx075.

7.

Designed α-sheet peptides suppress amyloid formation in Staphylococcus aureus biofilms.

Bleem A, Francisco R, Bryers JD, Daggett V.

NPJ Biofilms Microbiomes. 2017 Jul 3;3:16. doi: 10.1038/s41522-017-0025-2. eCollection 2017.

8.

Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations.

Carney RP, Hazari S, Colquhoun M, Tran D, Hwang B, Mulligan MS, Bryers JD, Girda E, Leiserowitz GS, Smith ZJ, Lam KS.

Anal Chem. 2017 May 16;89(10):5357-5363. doi: 10.1021/acs.analchem.7b00017. Epub 2017 Apr 25.

9.

Interruption of Electrical Conductivity of Titanium Dental Implants Suggests a Path Towards Elimination Of Corrosion.

Pozhitkov AE, Daubert D, Brochwicz Donimirski A, Goodgion D, Vagin MY, Leroux BG, Hunter CM, Flemmig TF, Noble PA, Bryers JD.

PLoS One. 2015 Oct 13;10(10):e0140393. doi: 10.1371/journal.pone.0140393. eCollection 2015.

10.

Antibacterial activity of gold-titanates on Gram-positive cariogenic bacteria.

Eiampongpaiboon T, Chung WO, Bryers JD, Chung KH, Chan DCN.

Acta Biomater Odontol Scand. 2015 Sep 18;1(2-4):51-58. doi: 10.3109/23337931.2015.1084883. eCollection 2015 Dec.

11.

A Single B-repeat of Staphylococcus epidermidis accumulation-associated protein induces protective immune responses in an experimental biomaterial-associated infection mouse model.

Yan L, Zhang L, Ma H, Chiu D, Bryers JD.

Clin Vaccine Immunol. 2014 Sep;21(9):1206-14. doi: 10.1128/CVI.00306-14. Epub 2014 Jun 11.

12.

Development of a poly(ether urethane) system for the controlled release of two novel anti-biofilm agents based on gallium or zinc and its efficacy to prevent bacterial biofilm formation.

Ma H, Darmawan ET, Zhang M, Zhang L, Bryers JD.

J Control Release. 2013 Dec 28;172(3):1035-44. doi: 10.1016/j.jconrel.2013.10.005. Epub 2013 Oct 17.

13.

Non-invasive in situ monitoring and quantification of TOL plasmid segregational loss within Pseudomonas putida biofilms.

Ma H, Katzenmeyer KN, Bryers JD.

Biotechnol Bioeng. 2013 Nov;110(11):2949-58. doi: 10.1002/bit.24953. Epub 2013 May 23.

14.

Giant extracellular matrix binding protein expression in Staphylococcus epidermidis is regulated by biofilm formation and osmotic pressure.

Linnes JC, Ma H, Bryers JD.

Curr Microbiol. 2013 Jun;66(6):627-33. doi: 10.1007/s00284-013-0316-7. Epub 2013 Feb 5.

15.
17.

Integrated bi-layered scaffold for osteochondral tissue engineering.

Galperin A, Oldinski RA, Florczyk SJ, Bryers JD, Zhang M, Ratner BD.

Adv Healthc Mater. 2013 Jun;2(6):872-83. doi: 10.1002/adhm.201200345. Epub 2012 Dec 6.

18.

Chitosan-based nanofibrous membranes for antibacterial filter applications.

Cooper A, Oldinski R, Ma H, Bryers JD, Zhang M.

Carbohydr Polym. 2013 Jan 30;92(1):254-9. doi: 10.1016/j.carbpol.2012.08.114. Epub 2012 Sep 7.

19.

Multifunctional triblock copolymers for intracellular messenger RNA delivery.

Cheng C, Convertine AJ, Stayton PS, Bryers JD.

Biomaterials. 2012 Oct;33(28):6868-76. doi: 10.1016/j.biomaterials.2012.06.020. Epub 2012 Jul 9.

20.
21.

Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.

Bryers JD, Giachelli CM, Ratner BD.

Biotechnol Bioeng. 2012 Aug;109(8):1898-911. doi: 10.1002/bit.24559. Epub 2012 May 24. Review.

22.

Effect of macrophage classical (M1) activation on implant-adherent macrophage interactions with Staphylococcus epidermidis: A murine in vitro model system.

Park KR, Bryers JD.

J Biomed Mater Res A. 2012 Aug;100(8):2045-53. doi: 10.1002/jbm.a.34087. Epub 2012 May 12.

23.

Adhesion of Staphylococcus epidermidis to biomaterials is inhibited by fibronectin and albumin.

Linnes JC, Mikhova K, Bryers JD.

J Biomed Mater Res A. 2012 Aug;100(8):1990-7. doi: 10.1002/jbm.a.34036. Epub 2012 May 5.

24.

Antimicrobial effects of nanofiber poly(caprolactone) tissue scaffolds releasing rifampicin.

Ruckh TT, Oldinski RA, Carroll DA, Mikhova K, Bryers JD, Popat KC.

J Mater Sci Mater Med. 2012 Jun;23(6):1411-20. doi: 10.1007/s10856-012-4609-3. Epub 2012 Mar 10.

25.

Diblock copolymers with tunable pH transitions for gene delivery.

Manganiello MJ, Cheng C, Convertine AJ, Bryers JD, Stayton PS.

Biomaterials. 2012 Mar;33(7):2301-9. doi: 10.1016/j.biomaterials.2011.11.019. Epub 2011 Dec 12.

26.

Modulation of fibroblast inflammatory response by surface modification of a perfluorinated ionomer.

Valdes TI, Ciridon W, Ratner BD, Bryers JD.

Biointerphases. 2011 Jun;6(2):43-53. doi: 10.1116/1.3583535.

27.

Sustained antibiotic release from an intraocular lens-hydrogel assembly for cataract surgery.

Garty S, Shirakawa R, Warsen A, Anderson EM, Noble ML, Bryers JD, Ratner BD, Shen TT.

Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6109-16. doi: 10.1167/iovs.10-6071.

PMID:
21447687
28.

Multivalent artificial opsonin for the recognition and phagocytosis of Gram-positive bacteria by human phagocytes.

Katzenmeyer KN, Bryers JD.

Biomaterials. 2011 Jun;32(16):4042-51. doi: 10.1016/j.biomaterials.2011.02.007.

29.

Non-invasive method to quantify local bacterial concentrations in a mixed culture biofilm.

Ma H, Bryers JD.

J Ind Microbiol Biotechnol. 2010 Oct;37(10):1081-9. doi: 10.1007/s10295-010-0756-z. Epub 2010 Jun 15.

30.

Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery.

Anderson EM, Noble ML, Garty S, Ma H, Bryers JD, Shen TT, Ratner BD.

Biomaterials. 2009 Oct;30(29):5675-81. doi: 10.1016/j.biomaterials.2009.06.047. Epub 2009 Jul 23.

31.

Zwitterionic carboxybetaine polymer surfaces and their resistance to long-term biofilm formation.

Cheng G, Li G, Xue H, Chen S, Bryers JD, Jiang S.

Biomaterials. 2009 Oct;30(28):5234-40. doi: 10.1016/j.biomaterials.2009.05.058. Epub 2009 Jul 1.

32.

Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Novak MT, Bryers JD, Reichert WM.

Biomaterials. 2009 Apr;30(11):1989-2005. doi: 10.1016/j.biomaterials.2008.11.025. Epub 2009 Jan 29. Review.

33.

Medical biofilms.

Bryers JD.

Biotechnol Bioeng. 2008 May 1;100(1):1-18. doi: 10.1002/bit.21838. Review.

34.

Surface modification of a perfluorinated ionomer using a glow discharge deposition method to control protein adsorption.

Valdes TI, Ciridon W, Ratner BD, Bryers JD.

Biomaterials. 2008 Apr;29(10):1356-66. Epub 2007 Dec 21.

35.

Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces.

Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S.

Biomaterials. 2007 Oct;28(29):4192-9. Epub 2007 Jun 29.

36.

Biomaterials approaches to combating oral biofilms and dental disease.

Bryers JD, Ratner BD.

BMC Oral Health. 2006 Jun 15;6 Suppl 1:S15.

37.

Biotech and biomaterials research to reduce the caries epidemic.

Slayton RL, Bryers JD, Milgrom P.

BMC Oral Health. 2006 Jun 15;6 Suppl 1:S1.

38.
39.

Effects of controlled fibronectin surface orientation on subsequent Staphylococcus epidermidis adhesion.

Jarvis RA, Bryers JD.

J Biomed Mater Res A. 2005 Oct 1;75(1):41-55.

PMID:
16059880
40.

Plasma deposition and surface characterization of oligoglyme, dioxane, and crown ether nonfouling films.

Johnston EE, Bryers JD, Ratner BD.

Langmuir. 2005 Feb 1;21(3):870-81.

PMID:
15667162
41.
43.
44.

Binding and orientation of fibronectin on polystyrene surfaces using immobilized bacterial adhesin-related peptides.

Klueh U, Bryers JD, Kreutzer DL.

J Biomed Mater Res A. 2003 Oct 1;67(1):36-43.

PMID:
14517859
45.

Binding and orientation of fibronectin to silanated glass surfaces using immobilized bacterial adhesin-related peptides.

Klueh U, Seery T, Castner DG, Bryers JD, Kreutzer DL.

Biomaterials. 2003 Oct;24(22):3877-84.

PMID:
12834582
46.
48.

Two-photon excitation microscopy for analyses of biofilm processes.

Bryers JD.

Methods Enzymol. 2001;337:259-69. Review. No abstract available.

PMID:
11398434
49.

Biofilm-induced gene expression and gene transfer.

Lamont RJ, Bryers JD.

Methods Enzymol. 2001;336:84-94. No abstract available.

PMID:
11398422
50.

Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation.

Klueh U, Wagner V, Kelly S, Johnson A, Bryers JD.

J Biomed Mater Res. 2000;53(6):621-31.

PMID:
11074419

Supplemental Content

Loading ...
Support Center